Healthcare provider profile · identity verified

Bernard Lee Ormsby, D.O.

Family Practice · FRENCH CAMP, CA · NPI 1144483314

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	601	94
Atorvastatin Calcium	Atorvastatin Calcium	510	171
Amlodipine Besylate	Amlodipine Besylate	495	186
Lisinopril	Lisinopril	301	103
Levothyroxine Sodium	Levothyroxine Sodium	262	74
Furosemide	Furosemide	241	81
Losartan Potassium	Losartan Potassium	237	79
Omeprazole	Omeprazole	210	68
Tamsulosin Hcl	Tamsulosin Hcl	172	54
Fluticasone Propionate	Fluticasone Propionate	156	49
Metformin Hcl Er	Metformin Hcl	149	54
Pantoprazole Sodium	Pantoprazole Sodium	146	36
Trazodone Hcl	Trazodone Hcl	145	46
Atenolol	Atenolol	133	39
Famotidine	Famotidine	129	38
Albuterol Sulfate Hfa	Albuterol Sulfate	127	63
Ibuprofen	Ibuprofen	113	37
Alendronate Sodium	Alendronate Sodium	111	42
Metoprolol Tartrate	Metoprolol Tartrate	109	33
Gabapentin	Gabapentin	102	32
Clopidogrel	Clopidogrel Bisulfate	99	33
Quetiapine Fumarate	Quetiapine Fumarate	99	23
Sertraline Hcl	Sertraline Hcl	99	30
Tramadol Hcl	Tramadol Hcl	97	25
Hydrochlorothiazide	Hydrochlorothiazide	85	28
Metoprolol Succinate	Metoprolol Succinate	82	30
Simvastatin	Simvastatin	82	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	76	22
Glipizide Er	Glipizide	72	24
Duloxetine Hcl	Duloxetine Hcl	68	23
Nabumetone	Nabumetone	65	29
Spiriva Respimat	Tiotropium Bromide	64	22
Alvesco	Ciclesonide	63	20
Potassium Chloride	Potassium Chloride	60	20
Wixela Inhub	Fluticasone Propion/Salmeterol	59	14
Prednisone	Prednisone	56	42
Clonidine	Clonidine	55	16
Meloxicam	Meloxicam	54	15
Terazosin Hcl	Terazosin Hcl	54	18
Glipizide	Glipizide	51	16
Spironolactone	Spironolactone	47	18
Triamcinolone Acetonide	Triamcinolone Acetonide	46	23
Clonidine Hcl	Clonidine Hcl	44	13
Fluoxetine Hcl	Fluoxetine Hcl	44	13
Lovastatin	Lovastatin	43	13
Tizanidine Hcl	Tizanidine Hcl	43	suppressed
Allopurinol	Allopurinol	42	13
Morphine Sulfate Er	Morphine Sulfate	40	suppressed
Humulin N	Insulin Nph Human Isophane	39	14
Hydralazine Hcl	Hydralazine Hcl	39	12
Pradaxa	Dabigatran Etexilate Mesylate	38	14
Carvedilol	Carvedilol	37	13
Clobetasol Propionate	Clobetasol Propionate	37	17
Montelukast Sodium	Montelukast Sodium	37	12
Hydroxyzine Hcl	Hydroxyzine Hcl	36	suppressed
Levetiracetam	Levetiracetam	36	suppressed
Metformin Hcl	Metformin Hcl	36	15
Zolpidem Tartrate	Zolpidem Tartrate	34	suppressed
Ipratropium Bromide	Ipratropium Bromide	33	21
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Mirtazapine	Mirtazapine	31	11
Jardiance	Empagliflozin	30	11
Rosuvastatin Calcium	Rosuvastatin Calcium	30	11
Acyclovir	Acyclovir	29	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	29	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	suppressed
Warfarin Sodium	Warfarin Sodium	29	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	28	suppressed
Lorazepam	Lorazepam	28	suppressed
Ozempic	Semaglutide	28	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	26	12
Baclofen	Baclofen	25	suppressed
Lactulose	Lactulose	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	23	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	11
Donepezil Hcl	Donepezil Hcl	23	suppressed
Ondansetron Odt	Ondansetron	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Pravastatin Sodium	Pravastatin Sodium	21	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	17
Cefadroxil	Cefadroxil	19	19
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	19	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Naproxen	Naproxen	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	18	suppressed
Betamethasone Valerate	Betamethasone Valerate	17	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	17	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Eliquis	Apixaban	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	15	suppressed
Nystatin	Nystatin	15	11
Temazepam	Temazepam	15	suppressed
Carbamazepine Er	Carbamazepine	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Tacrolimus	Tacrolimus	14	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	13	13
Fenofibrate	Fenofibrate	13	suppressed
Humulin R	Insulin Regular, Human	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Trospium Chloride	Trospium Chloride	13	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	11
Cromolyn Sodium	Cromolyn Sodium	11	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error